The Clinical Effect of Danhong Tongjing Formula and Conventional Western Medicine in the Treatment of Acute Cerebral Infarction and Its Influence on Serum C-reactive Protein and Nerve Function Defect
Jiang Xiuyun
Wu Mengjiao
Ren Jumin
Yang Fan
Xu Guowei
Abstract：Objective To analyze the clinical curative effect of Danhong Tongjing formula (DTF) and conventional western medicine in the treatment of acute cerebral infarction (ACI) and its influence on serum C-reactive protein (CRP) and nerve function defect.Methods Seventy-eight patients with ACI were selected from February 2015 to January 2016 and divided into two groups:control group (n=39) treated with edaravone,and treatment group(n=39) treated with edaravone and DTF for 14 days.The National Institutes of Health Stroke Scale (NIHSS), serum C reactive protein (CRP) levels were observed before and after treatment.The clinical efficacy and adverse reaction were observed.Results After treatment, NIHSS scores and CRP levels in treatment group were lower than that in control group [(7.51 ± 2.65) vs (11.73 ±7.22) , P<0.05;(7.01± 2.32) mg/L vs (14.03± 5.01) mg/L, P<0.05].The total efficiency in treatment group was higher than that in control group (92.31% vs 74.36%, P<0.05).The incidence of adverse reaction was 10.25% in treatment group and 12.81% in control group (P>0.05).Conclusion DTF and conventional western medicine can effectively reduce the level of serum CRP, improve neurological function, improve the therapeutic effect, and does not increase the incidence of adverse reaction.
Keywords：acute cerebral infarctionDanhong Tongjing formulaedaravoneserum C-reactive proteinnerve function defect
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 1103-1106 )